Celaid Therapeutics

Celaid Therapeutics is a Japan-based biotechnology company, which has developed a platform technology to efficiently expand hematopoietic stem cells ex vivo without choosing its origins, including bone marrow, cord blood, or peripheral blood. By using the novel technology, we are developing a cell therapy product that brings HSC transplantation to the next level and helps patients with blood disorders. Our technology has many potential applications including gene/cell therapy that utilize gene editing on HSC. Our mission is to improve QOL of patients, their families, and HSC donors all over the world

再生医療,バイオテクノロジー,細胞治療,造血幹細胞,試薬・培地,and がん領域

Celaid therapeutics operates in the Biotechnology industry.

Celaid therapeutics's revenue is 11m - 100m

Celaid therapeutics has 11 - 50 employees.